Literature DB >> 6687400

Prevalence of increased intraocular pressure in Graves' disease--evidence of frequent subclinical ophthalmopathy.

G T Gamblin, D G Harper, P Galentine, D R Buck, B Chernow, C Eil.   

Abstract

Graves' exophthalmos is frequently associated with elevated intraocular pressure on upgaze. Eighty patients with Graves' disease were evaluated prospectively by applanation tonometry to assess the prevalence of ophthalmopathy in this disorder. Whereas 21 (26 per cent) of the 80 patients had exophthalmos, 61 (76 per cent) had abnormal intraocular pressure (delta greater than or equal to 3 mm Hg). All patients with exophthalmos had elevated intraocular pressure on upgaze; 40 (68 per cent) of 59 patients without proptosis had abnormal pressure readings. The mean interval between the onset of Graves' disease and this study was 6.3 +/- 1.0 years (S.E.M.) for those patients who had exaggerated positional changes in intraocular pressure, as compared with 3.0 +/- 1.0 years for those with normal intraocular pressure (P less than 0.005). All but 1 of 15 patients in whom the diagnosis of Graves' disease had been documented 10 or more years earlier had increased intraocular pressure on upgaze. We conclude that Graves' ophthalmopathy is more common than is recognized clinically and that eye involvement is an inevitable complication of the disease.

Entities:  

Mesh:

Year:  1983        PMID: 6687400     DOI: 10.1056/NEJM198302243080803

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  24 in total

Review 1.  Autoimmunity in Graves' ophthalmopathy: a review.

Authors:  A P Weetman
Journal:  J R Soc Med       Date:  1989-03       Impact factor: 5.344

2.  Is gaze-dependent tonometry a useful tool in the differential diagnosis of Graves' ophthalmopathy?

Authors:  Daniel Herzog; Rafael Hoffmann; Irene Schmidtmann; Norbert Pfeiffer; Paul-Rolf Preussner; Susanne Pitz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-08-27       Impact factor: 3.117

Review 3.  Immunosuppressant therapy of thyroid eye disease.

Authors:  G Kahaly; J Beyer
Journal:  Klin Wochenschr       Date:  1988-11-01

4.  Long-term follow-up of ophthalmic Graves' disease.

Authors:  P J Agapitos; I R Hart
Journal:  CMAJ       Date:  1987-02-15       Impact factor: 8.262

5.  Intravenous methylprednisolone in the treatment of Graves' ophthalmopathy.

Authors:  P Kendall-Taylor; A L Crombie; A M Stephenson; M Hardwick; K Hall
Journal:  BMJ       Date:  1988-12-17

6.  Temporal relationship between onset of Graves' ophthalmopathy and onset of thyroidal Graves' disease.

Authors:  W M Wiersinga; T Smit; R van der Gaag; L Koornneef
Journal:  J Endocrinol Invest       Date:  1988-09       Impact factor: 4.256

7.  Intraocular pressure changes in secondary positions of gaze in normal subjects and in restrictive ocular motility disorders.

Authors:  M Nardi; M P Bartolomei; A Romani; L Barca
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

Review 8.  Ocular manifestations of Graves' disease: a review.

Authors:  A P Weetman; A M McGregor; R Hall
Journal:  J R Soc Med       Date:  1984-11       Impact factor: 5.344

9.  Clinical significance of a new autoantibody against a human eye muscle soluble antigen, detected by immunofluorescence.

Authors:  M Mengistu; E Laryea; A Miller; J R Wall
Journal:  Clin Exp Immunol       Date:  1986-07       Impact factor: 4.330

10.  Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves' orbitopathy: relation with the clinical features.

Authors:  Onur Konuk; Zafer Onaran; Suna Ozhan Oktar; Cem Yucel; Mehmet Unal
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-16       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.